Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of the study is to: • Determine the effect of ranolazine on hemoglobin A1c (HbA1c) after 24 weeks of treatment when added to glimepiride in subjects who have inadequately controlled type 2 diabetes mellitus (T2DM) despite current treatment with stable sulfonylurea (SU) or metformin therapy in addition to diet and exercise
Critère d'inclusion
- Type 2 diabetes mellitus